Deafferentation of the septo-hippocampal pathway in rats as a model of the metabolic events in Alzheimer's disease

International Journal of Developmental Neuroscience

Volumn 19, Issue 3, 2001, Pages 263-277

  Krügel, Ute ^a   Bigl, Volker ^a   Eschrich, Klaus ^a   Bigl, Marina ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Alzheimer's disease; Cholinergic system; Fimbria fornix; Glial fibrillary acidic protein; Glucose and energy metabolism; Glucose transport

Indexed keywords

ACETYLCHOLINESTERASE; ARYLAMINE ACETYLTRANSFERASE; CHOLINE ACETYLTRANSFERASE; CYTOCHROME C OXIDASE; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUCOSE TRANSPORTER; MITOCHONDRIAL ENZYME;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ASTROCYTOSIS; BRAIN METABOLISM; CELL FRACTIONATION; CHOLINERGIC SYNAPSE; CONFERENCE PAPER; CONTROLLED STUDY; DEAFFERENTATION; DENTATE GYRUS; ENERGY METABOLISM; ENZYME ACTIVITY; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; HIPPOCAMPUS; MALE; NERVE DEGENERATION; NONHUMAN; PRIORITY JOURNAL; RAT; WESTERN BLOTTING;

ACETYLCHOLINESTERASE; AFFERENT PATHWAYS; ALZHEIMER DISEASE; ANIMALS; ASTROCYTES; BASAL NUCLEUS OF MEYNERT; CHOLINE O-ACETYLTRANSFERASE; CHOLINERGIC FIBERS; DENERVATION; DIAGONAL BAND OF BROCA; DISEASE MODELS, ANIMAL; ELECTRON TRANSPORT COMPLEX IV; ENERGY METABOLISM; FORNIX (BRAIN); GENE EXPRESSION REGULATION, ENZYMOLOGIC; GLIAL FIBRILLARY ACIDIC PROTEIN; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASES; GLYCOLYSIS; HIPPOCAMPUS; HUMANS; MALE; MITOCHONDRIA; PHOSPHOFRUCTOKINASE-1; PYRUVATE DEHYDROGENASE COMPLEX; RATS; RATS, WISTAR; RNA, MESSENGER;

ANIMALIA;

EID: 0035040747     PISSN: 07365748     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0736-5748(01)00010-7     Document Type: Conference Paper

References (91)

1. A histochemical method for the demonstration of acetylcholinesterase activity using semipermeable membranes
2. Reversible inhibition of acetylcholine synthesis and behavioural effects caused by 3-bromopyruvate
3. Degeneration of rat cholinergic basal forebrain neurons and reactive changes in nerve growth factor expression after chronic neurotoxic injury - II. Reactive expression of the nerve growth factor gene in astrocytes
4. Plastic neuronal remodeling is impaired in patients with Alzheimer's disease carrying apolipoprotein epsilon 4 allele
5. Distribution of cholinergic neurons in rat brain: demonstrated by the immunocytochemical localization of choline acetyltransferase
6. Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease
7. Comparative alterations of nicotinic and muscarinic binding sites in Alzheimer's and Parkinson's diseases
8. The cholinergic hypothesis: a historical overview, current perspective, and future directions
9. Selective memory loss following nucleus basalis lesions: long term behavioral recovery despite persistent cholinergic deficiencies
10. Deafferentation removes calretinin immunopositive terminals, but does not induce degeneration of calbindin D-28k and parvalbumin expressing neurons in the hippocampus of adult rats
11. Modified microassay for the rapid and sensitive determination of choline acetyltransferase activity using (3H)-acetyl-COA and Fonnum's extraction
12. Changes of activity and isozyme pattern of phosphofructokinase in the brains of patients with Alzheimer's disease
13. Activities of key glycolytic enzymes in the brains of patients with Alzheimer's disease
14. Altered phosphofructokinase mRNA levels but unchanged isoenzyme pattern in brains from patients with Alzheimer's disease
15. Accelerated ageing or selective neuronal loss as an important cause of dementia
16. Biochemical assessment of serotonergic and cholinergic dysfunction and cerebral atrophy in Alzheimer's disease
17. Thiamine-dependent enzyme changes in temporal cortex of patients with Alzheimer's disease
18. The fimbria-fornix/singular bundle pathways: a review of neurochemical and behavioural approaches using lesions and transplantation techniques
19. Evidence for physiological down-regulation of brain oxidative phosphorylation in Alzheimer's disease
20. The role of neuronal growth factors in neurodegenerative disorders of the human brain
21. Brain function, synapse renewal, and plasticity
22. The radiologic prediction of Alzheimer disease: the atrophic hippocampal formation
23. Positron emission tomography in Alzheimer's disease
24. A rapid Percoll gradient procedure for isolation of synaptosomes directly from an 51 fraction: homogeneity and morphology of subcellular fractions
25. Cholinergic blockade in prefrontal cortex and hippocampus disrupts short-term memory in rats
26. The septohippocampal pathway: structure and function of a central cholinergic system
27. Glucose metabolism during the final stage of human oocyte maturation: genetic expression of hexokinase, glucose phosphate isomerase and phosphofructokinase
28. A new rapid colorimetric determination of acetylcholinesterase activity
29. Engagement of ICAM-3 activates polymorphonuclear leukocytes: aggregation without degranulation or β2 integrin recruitment
30. A rapid radiochemical method for the determination of choline acetyltransferase
31. Regional cerebral oxygen supply and utilization in dementia. A clinical and physiological study with oxygen-15 and positron tomography
32. Influence of chronic alcohol treatment on the GFAP-immunoreactivity in astrocytes of the hippocampus in rats
33. GABA-containing neurons in the septum control inhibitory interneurons in the hippocampus
34. Functional correlates of compensatory collateral sprouting by aminergic and cholinergic afferents in the hippocampal formation
35. Retrograde cell changes in medial septum and diagonal band following fimbria-fornix transection: quantitative temporal analysis
36. Astrocytes are important for sprouting in the septohippocampal circuit
37. Reduced activities of thiamine-dependent enzymes in the brains and peripheral tissues of patients with Alzheimer's disease
38. Implications of multiple transmitter system lesions for cholinomimetic therapy in Alzheimer's disease
39. The cholinergic model of dementia, Alzheimer type: progressionfrom the unitary transmitter concept
40. Glucose metabolism as the site of the primary abnormality in early-onset dementia of Alzheimer type
41. Models of Alzheimer's disease: cellular and molecular aspects
42. Memory-related neural systems in Alzheimer's disease: an anatomic study
43. MRI-based quantitative assessment of the hippocampal region in very mild to moderate Alzheimer's disease
44. Paradoxical hippocampus perfusion in mild-to-moderate Alzheimer's disease
45. Glycolytic enzymes from human autoptic brain cortex: normal aged and demented cases
46. Differential effects of electrical stimulation of sciatic nerve on metabolic activity in spinal cord and dorsal root ganglion in the rat
47. Abnormalities of the glucose transporter at the blood-brain barrier and in brain in Alzheimer's disease
48. Neurochemistry of Alzheimer's disease
49. Brain cytochrome oxidase in Alzheimer's disease
50. Studies on the pyruvate dehydrogenase complex in brain with the arylamine acetyltransferase-coupled assay
51. Impaired brain glucose metabolism in patients with down syndrome
52. Cleavage of structural proteins during the assembly of the head of bacteriophage T4
53. Compensatory changes of in vivo acetylcholine and noradrenaline release in the hippocampus after partial deafferentation, as monitored by microdialysis
54. Depot-specific differences in adipose tissue gene expression in lean and obese subjects
55. Glucose transporters, hexokinase, and phosphofructokinase in brain of rats with perinatal asphyxia
56. Neurotransmitter deficits in Alzheimer's disease and in other dementing disorders
57. Glucose metabolism in cholinoceptive cortical rat brain regions after basal forebrain cholinergic lesion
58. Changes in brain glucose metabolism as a key to the pathogenesis of Alzheimer's disease
59. Alteration of PFK subunit protein, synthesis, and mRNA during neonatal brain development
60. Regional cerebral glucose metabolism and postmortem pathology in Alzheimer's disease
61. Discordance between traditional pathologic and energy metabolic changes in very early Alzheimer's disease. Pathophysiological implications
62. Mitochondrial enzyme expression in the hippocampus in relation to Alzheimer-type pathology
63. Acetylcholine release in the hippocampus: regulation by monoaminergic afferents as assessed by in vivo microdialysis
64. Imaging of nicotinic and muscarinic receptors in Alzheimer's disease: effect of tacrine treatment
65. Astrocyte responses to CNS injury
66. Nerve growth factor affects 11C-nicotine binding, blood flow, EEG, and verbal episodic memory in an Alzheimer patient (case report)
67. Spatial memory and hippocampal function
68. Deregulation of glucose transporter 1 and glycolytic gene expression by c-Myc
69. Alterations in hippocampal expression of SNAP-25, GAP-43, stannin and glial fibrillary acidic protein following mechanical and trimethyltin-induced injury in the rat
70. Coenzyme A-acetylating enzymes in Alzheimer's disease: possible cholinergic 'compartment' of pyruvate dehydrogenase
71. Neuroglia: quantitative aspects
72. Septum and medial frontal cortex contribution to spatial problem-solving
73. Functional alterations in Alzheimer's disease: selective loss of mitochondrial-encoded cytochrome oxidase mRNA in the hippocampal formation
74. Reduced glucose transporter concentrations in brains of patients with Alzheimer's disease
75. Decreased concentrations of GLUT1 and GLUT3 glucose transporters in the brains of patients with Alzheimer's disease
76. 2 from [U-l4C] glucose in vitro in human neocortex
77. Phosphofructokinase activity in the brain in Alzheimer's disease
78. Contribution of astroglia to functionally activated energy metabolism
79. Decreased pyruvate dehydrogenase complex activity in Huntington and Alzheimer brain
80. Energy metabolism in demented brain
81. Cholecystokinin-8 protects central cholinergic neurons against fimbria-fornix lesion through the up-regulation of nerve growth factor synthesis
82. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications
83. Autoradiography of [3H]cytochalasin B binding in rat brain
84. Selective increase of NMDA-sensitive glutamate binding in the striatum of Parkinson's disease, Alzheimer's disease, and mixed Parkinson's disease/Alzheimer's disease patients: an autoradiographic study
85. Laminar alterations in gamma-aminobutyric acid-A, muscarinic, and β-adrenoceptors and neuron degeneration in cingulate cortex in Alzheimer's disease
86. Increased proliferation of precursor cells in the adult rat brain after targeted lesioning
87. Neurotransmitters and memory: role of cholinergic, serotonergic, and noradrenergic systems
88. Increased β-nerve growth factor messenger RNA and protein levels in neonatal rat hippocampus following specific cholinergic lesions
89. Plasticity and neurotransmitter receptor changes in Alzheimer's disease and experimental cortical infarcts